Table 3.
Infection-related Clinical Complications Prognostic Parameters.
| GP (A) Survivors (1139) |
GP (B) Non-Survivors (349) |
p-Value | |
|---|---|---|---|
| INR (0.9–1.2) |
1.12 (0.29) | 1.25 (0.69) | 0.003 * |
| D-dimer (0.22–0.46 FEU µg/mL) |
2.96 (9.48) | 4.98 (11.92) | 0.029 * |
| Urea (2.5–7.8 mmol/L) |
6.90 (5.70) | 11.43 (7.74) | 0.0001 * |
| Albumin (35–50 g/L) |
38.37 (11.66) | 33.52 (4.92) | 0.0001 * |
| Bilirubin (<21 µmol/L) |
10.56 (10.98) | 13.11 (15.30) | 0.005 * |
| ALP (30–130 IU/L) |
95.13 (59.73) | 117.13 (128.61) | 0.003 * |
| ALT (4–36 U/L) |
40.77 (48.69) | 43.90 (80.85) | 0.510 |
| CRE (45–110 µmol/L) |
102.43 (9795) | 130.91 (77.09) | 0.0001 * |
| CRP (<1 mg/L) |
84.53 (82.43) | 118.56 (91.51) | 0.0001 * |
| FER (41–400 μg/L) |
854.92 (1324.32) | 1180.42 (1818.14) | 0.021 * |
| LDH (140–280 U/L) |
442.18 (259.71) | 507.349 (341.38) | 0.032 * |
| cTnI (<14 ng/L) |
207.37 (2256.01) | 219.96 (1038.96) | 0.938 |
| 25-OHD (25–40 ng/mL) |
43.53 (31.05) | 46.65 (41.97) | 0.253 |
Abbreviations: INR, international normalized ratio; ALP, alkaline phosphatase; ALT, Alanine transaminase; CRE, creatinine; CRP, C-reactive protein; FER, ferritin; LDH, lactate dehydrogenase; cTnI, cardiac troponin-I; 25OHD, 25-hydroxycholecalciferol. * Significant p-values are indicated where p < 0.05 was considered significant.